Genetically Targeted Clinical Trials in Parkinson's Disease: Learning from the Successes Made in Oncology.

Genes (Basel) · 2021 · PMC8535305 · PMID 34680924

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Secondly, disease modification trials typically have long durations (years) and there may be significant competition for eligible patients carrying a specific genotype.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.